"Extracorporeal photopheresis (ECP) is the first FDA approved cellular photoimmunotherapy for cancer and has demonstrated efficacy in T-cell mediated disorders including prevention and treatment of acute and chronic graft-versus-host disease, organ transplant rejection, scleroderma, Crohn s disease and diabetes mellitus. Due to its exceptional safety profile ECP has gained wide international acceptance through the efforts of leading clin ..."
"Int] Cancer 1998;78:70-5. [9] Bellone M, Iezzi G, Rovere P, et al. Processingof
engulfed apoptotic bodies yields T cell epitopes.] Immunol1997;159:5391—9. [10
] ZangYC, Hong], Rivera VM, Killian ], Zhang]Z. Preferential recognition of TCR
hypervariable regions by human anti-idiotypic T cells induced by T cell
vaccination. ] Immunol 2000;164:4011-7. [11] RookAH, Suchin KR, Kao DMF, et
al. Photopheresis: clinical applications and mech ..."
"Extracorporeal photopheresis (ECP) is the first FDA approved cellular photoimmunotherapy for cancer and has demonstrated efficacy in T-cell mediated disorders including prevention and treatment of acute and chronic graft-versus-host disease, organ transplant rejection, scleroderma, Crohn s disease and diabetes mellitus. Due to its exceptional safety profile ECP has gained wide international acceptance through the efforts of leading clin ..."